1. Home
  2. COCP vs IPA Comparison

COCP vs IPA Comparison

Compare COCP & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • IPA
  • Stock Information
  • Founded
  • COCP N/A
  • IPA 1983
  • Country
  • COCP United States
  • IPA Canada
  • Employees
  • COCP N/A
  • IPA N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • IPA Biotechnology: Pharmaceutical Preparations
  • Sector
  • COCP Health Care
  • IPA Health Care
  • Exchange
  • COCP Nasdaq
  • IPA Nasdaq
  • Market Cap
  • COCP 18.3M
  • IPA 18.9M
  • IPO Year
  • COCP N/A
  • IPA 2017
  • Fundamental
  • Price
  • COCP $2.15
  • IPA $0.44
  • Analyst Decision
  • COCP Strong Buy
  • IPA Strong Buy
  • Analyst Count
  • COCP 1
  • IPA 2
  • Target Price
  • COCP $7.00
  • IPA $6.00
  • AVG Volume (30 Days)
  • COCP 22.2K
  • IPA 1.1M
  • Earning Date
  • COCP 11-13-2024
  • IPA 12-12-2024
  • Dividend Yield
  • COCP N/A
  • IPA N/A
  • EPS Growth
  • COCP N/A
  • IPA N/A
  • EPS
  • COCP N/A
  • IPA N/A
  • Revenue
  • COCP N/A
  • IPA $17,441,886.00
  • Revenue This Year
  • COCP N/A
  • IPA $4.33
  • Revenue Next Year
  • COCP N/A
  • IPA $35.64
  • P/E Ratio
  • COCP N/A
  • IPA N/A
  • Revenue Growth
  • COCP N/A
  • IPA 11.21
  • 52 Week Low
  • COCP $1.33
  • IPA $0.35
  • 52 Week High
  • COCP $3.10
  • IPA $2.60
  • Technical
  • Relative Strength Index (RSI)
  • COCP 64.04
  • IPA 40.98
  • Support Level
  • COCP $1.65
  • IPA $0.40
  • Resistance Level
  • COCP $1.82
  • IPA $0.53
  • Average True Range (ATR)
  • COCP 0.17
  • IPA 0.07
  • MACD
  • COCP 0.03
  • IPA 0.00
  • Stochastic Oscillator
  • COCP 64.10
  • IPA 37.76

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About IPA ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.

Share on Social Networks: